mProX™ Human LATS2 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Kinase Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Robert
Verified Customer
Anthony
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 LATS2 alterations in MPM cells in culture.
LATS2 mRNA and protein were expressed by MPM without mutation. Only those MPM exhibiting significant exon deletions showed complete reduction of mRNA expression. Only the MPM in culture with missense mutation (MPM_04) displayed LATS2 protein expression out of the seven LATS2 mutants.
Ref: Tranchant, Robin, et al. "Co-occurring mutations of tumor suppressor genes, LATS2 and NF2, in malignant pleural mesothelioma." Clinical Cancer Research 23.12 (2017): 3191-3202.
Pubmed: 28003305
DOI: 10.1158/1078-0432.CCR-16-1971
Research Highlights
According to available data, the MOB1 scaffold protein and the hippocampal kinases MST1/2 encourage the development of active MOB1/LATS complexes, which phosphorylate and inhibit YAP1.
Hoa, Lily, et al. "The characterisation of LATS2 kinase regulation in Hippo-YAP signalling." Cellular signalling 28.5 (2016): 488-497.
Pubmed:
26898830
DOI:
10.1016/j.cellsig.2016.02.012
According to this study, LATS2 O-GlcNAcylation plays a crucial part in the deregulation of the Hippo pathway in cancer cells, which is directly linked to the formation of tumors.
Kim, Eunah, et al. "O-GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity." Proceedings of the National Academy of Sciences 117.25 (2020): 14259-14269.
Pubmed:
32513743
DOI:
10.1073/pnas.1913469117